Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: A pilot study of clinical and radiologic response

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1285-1291

  De Deus Cardoso, Cejana Casimiro ^a   Giordani, Adelmo José ^a   Wolosker, Ângela Maria Borri ^a   Souhami, Luis ^b   Manso, Paulo Gois ^a   Dias, Rodrigo Souza ^a   Segreto, Helena Regina Comodo ^a   Segreto, Roberto Araujo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Altered fractionation; Graves' ophthalmopathy; Hypofractionation; Magnetic resonance imaging; Radiotherapy

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAGNETISM; RESONANCE;

CLINICAL RESPONSE; GRAVES' OPHTHALMOPATHY; HYPOFRACTIONATED RADIOTHERAPIES; HYPOFRACTIONATION; METHODS AND MATERIALS; PHYSICAL EXAMINATIONS; RADIOLOGIC RESPONSE; STATISTICAL DIFFERENCES;

RADIOTHERAPY;

STEROID;

CLINICAL ARTICLE; CLINICAL EVALUATION; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EPIPHORA; EXTRAOCULAR MUSCLE; EYE MOVEMENT; EYE PAIN; EYELID EDEMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTRACTED HYPOFRACTIONATED RADIOTHERAPY; QUESTIONNAIRE; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY;

EID: 84856374928     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.015     Document Type: Article

References (27)

1. T.F. Davies, and P.R. Larsen Thyrotoxicosis P.R. Larsen, H.M. Kronenberg, S. Melmed, Williams textbook of endocrinology 10th ed 2002 W. B. Saunders Philadelphia 374 403
2. J. Ginsberg Diagnosis and management of Graves' disease CMAJ 168 2003 575 584
3. C.A. Perez, L.W. Brady, and E.C. Halperin Principles and practice of radiation oncology 4th ed. 2004 Lippincott Williams & Wilkins Philadelphia
4. G.J. Kahaly, H.P. Rosler, and S. Pitz Low- versus high-dose radiotherapy for Graves ophthalmopathy: A randomized, single blind trial J Clin Endocrinol Metabol 85 2000 102 108
5. J. Gerling, G. Kommerell, and K. Henne Retrobulbar irradiation for thyroid-associated orbitopathy: Double blind comparison between 2.4 and 16 Gy Int J Radiat Oncol Biol Phys 55 2003 182 189
6. C. Balázc Graves' orbitopathy [Abstract] Orv Hetil 147 2006 1011 1017
7. H.A. Eich, O. Micke, and M.H. Seegenschmiedt Radiotherapy of Graves' ophthalmopathy: State of the art and review of the literature [Abstract] Rontgenpraxis 56 2007 137 144
8. L. Vilar Endocrinologia clínica 2nd ed. 2001 Medsi Rio de Janeiro
9. P. Perros, and G.E. Krassas Orbital irradiation for thyroid-associated orbitopathy: Conventional dose, low dose or no dose? Clin Endocrinol 56 2002 689 691
10. M. Mourits, L. Koornneef, and W.M. Wiersinga Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: A novel approach Br J Ophthalmol 73 1989 639 644
11. A. Agresti Categorical data analysis 1990 Wiley Interscience New York p.349
12. O. Micke, M.H. Seegenschmiedt German Working Group on Radiotherapy in Germany Consensus guidelines for radiation therapy of benign diseases: A multicenter approach in Germany Int J Radiat Oncol Biol Phys 52 2002 496 513
13. C. Marcocci, L. Bartalena, and R. Rocchi Long-term safety of orbital radiotherapy for Graves' ophthalmopathy J Clin Endocrinol Metabol 88 2003 3561 3566
14. C.M. Ng, H.K.L. Yuen, and K.L. Choi Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: A preliminary study Hong Kong Med J 11 2005 322 330
15. M.F. Prummel, M.P. Mourits, and L. Blank Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy Lancet 342 1993 949 954
16. C. Marcocci, L. Bartalena, and M.L. Tanda Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study J Clin Endocrinol Metabol 86 2001 3562 3567
17. L. Bartalena, L. Baldeschi, and A. Dickinson Consensus stament of the European Group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy Thyroid 18 2008 333 346
18. C. Marcocci, L. Bartalena, and F. Bogazzi Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: Results of a prospective randomized study J Endocrinol Invest 10 1991 853 860
19. K. Ohtsuka, A. Sato, and S. Kawaguchi Effect of steroid pulse therapy with or without radiotherapy on Graves' ophthalmopathy Am J Ophthalmol 135 2003 285 290
20. K.P. Cockerham, and J.S. Kennerdell Does radiotherapy have a role in the management of thyroid orbitopathy? View 1: Debate Br J Ophthalmol 86 2002 102 104
21. I.A. Petersen, J.P. Kriss, and I.R. McDougall Prognostic factors in the radiotherapy of Graves' ophthalmopathy Int J Radiat Oncol Biol Phys 19 1990 259 264
22. L. Bartalena, C. Marcocci, and L. Chiovato Orbital cobalt irradiation combined with systemic corticosteroids alone J Clin Metab 56 1983 1139 1144
23. M. Just, G. Kahaly, and H.P. Higer Graves ophthalmopathy: Role of MR imaging in radiation therapy Radiology 179 1991 187 190
24. S.D. Marquez, B.L. Lum, and I.R. McDougall Long term results of irradiation for patients with progressive Graves' ophthalmopathy Int J Radiat Oncol Biol Phys 51 2001 766 774
25. E.A. Bradley, E.W. Gower, and D.J. Bradley Orbital radiation for Graves ophthalmopathy: A report by the American Academy of Ophthalmology Ophthalmology 115 2008 398 409
26. U. Schaefer, S. Hesselman, and O. Micke A long-term follow-up study after retro-orbital irradiation for Graves' opthalmopathy Int J Radiat Oncol Biol Phys 52 2002 192 197
27. R.S. Bahn Graves' ophthalmopathy N Engl J Med 362 2010 726 738